Zobrazeno 1 - 10
of 750
pro vyhledávání: '"M. A. Fox"'
Publikováno v:
All Results Journals: Biol, Vol 5, Iss 4, Pp 30-36 (2014)
Extracellular matrix (ECM) remodeling is accomplished largely by matrix metalloproteinases (MMPs), which cleave individual components of the ECM to facilitate cell migration. Tissue inhibitors of metalloproteinases (TIMPs) are secreted MMP inhibitors
Externí odkaz:
https://doaj.org/article/d1d9df7a639348138d5ea916b88f060b
Publikováno v:
The Scientific World Journal, Vol 2014 (2014)
Extracellular matrix (ECM) remodeling is essential for facilitating developmental processes. ECM remodeling, accomplished by matrix metalloproteinases (MMPs), is regulated by endogenous tissue inhibitors of metalloproteinases (TIMPs). While the TIMP
Externí odkaz:
https://doaj.org/article/dd2a337b917b44c985698d96bbf78e09
Autor:
A T Brennan, E M Kileel, M P Fox, J A George, S Khoza, S Rosen, F Raal, P Hibberd, K Chetty, K Mlisana, J Bor, N J Crowther
Publikováno v:
PLOS Global Public Health, Vol 4, Iss 9, p e0003014 (2024)
Diabetes is a major global health issue. We evaluated compliance to laboratory-based management guidelines for diabetes (type 1 and 2), essential for effective treatment and reducing diabetes-related morbidity and mortality. Our study utilized South
Externí odkaz:
https://doaj.org/article/30e8920efb10445ca6ee0a9ec9bfa8a7
Autor:
Ruben A. Mesa, Stacie Hudgens, Lysbeth Floden, Claire N. Harrison, Jeanne Palmer, Vikas Gupta, Donal P. McLornan, Mary F. McMullin, Jean‐Jaques Kiladjian, Lynda Foltz, Uwe Platzbecker, M. Laura Fox, Adam J. Mead, David M. Ross, Stephen T. Oh, Andrew Perkins, Michael F. Leahy, Samineh Deheshi, Rafe Donahue, Barbara J. Klencke, Srdan Verstovsek
Publikováno v:
Cancer Medicine, Vol 12, Iss 9, Pp 10612-10624 (2023)
Abstract Background Myelofibrosis (MF)‐associated constitutional symptoms can severely impact health‐related quality of life. Clinical trials in MF traditionally measure symptom response to treatment as a landmark endpoint of total symptom score
Externí odkaz:
https://doaj.org/article/e6eb999637b34b008d60fd675f19d445
Autor:
F. Passamonti, J. Foran, A. Tandra, V. De Stefano, M. Laura Fox, A. Mattour, M. F. McMullin, A. C. Perkins, G. Rodriguez-Macías, H. Sibai, Q. Qin, J. Potluri, J. How
Publikováno v:
HemaSphere, Vol 6, Pp 98-99 (2022)
Externí odkaz:
https://doaj.org/article/6c02eb2c0dbb4970bbe76f0ccf40409f
Autor:
S. Verstovsek, A. Vannucchi, A. Gerds, H. K. Al-Ali, D. Lavie, A. Kuykendall, S. Grosicki, A. Iurlo, Y. T. Goh, M. Lazaroiu, M. Egyed, M. L. Fox, D. McLornan, A. Perkins, S.-S. Yoon, V. Gupta, J.-J. Kiladjian, R. Donahue, J. Kawashima, R. Mesa
Publikováno v:
HemaSphere, Vol 6, Pp 96-97 (2022)
Externí odkaz:
https://doaj.org/article/96e126c4aa39416eb64bd19606a009a2
Autor:
T. Barbui, A. Carobbio, A. Masciulli, A. Iurlo, M. A. Sobas, E. M. Elli, E. Rumi, V. De Stefano, F. Lunghi, M. Marchetti, R. Daffini, M. Gasior Kabat, B. Cuevas, M. L. Fox, M. M. Andrade Campos, F. Palandri, P. Guglielmelli, G. Benevolo, C. Harrison, M. A. Foncillas, M. Bonifacio, A. Alvarez-Larran, J.-J. Kiladjian, E. Bolanos Calderon, A. Patriarca, K. S. Quiroz Cervantes, M. Griesshammer, V. Garcia-Gutierrez, A. Marin Sanchez, E. Magro Mazo, M. Ruggeri, J. C. Hernandez-Boluda, S. Osorio, G. Carreno-Tarragona, M. Sagues Serrano, R. Kusec, B. Navas Elorza, A. Angona, B. Xicoy Cirici, E. Lopez Abadia, S. Koschmieder, E. Cichocka, A. Kulikowska de Nałęcz, M. Bellini, D. Cattaneo, C. Bucelli, F. Cavalca, O. Borsani, S. Betti, N. Curto-Garcia, S. Carbonell, L. Benajiba, A. Rambaldi, A. M. Vannucchi
Publikováno v:
HemaSphere, Vol 6, Pp 899-900 (2022)
Externí odkaz:
https://doaj.org/article/9986d19608d246e4b0f9027a154020f7
Autor:
A. Vannucchi, R. Mesa, A. Gerds, H. K. Al-Ali, D. Lavie, A. Kuykendall, S. Grosicki, A. Iurlo, Y. T. Goh, M. Lazaroiu, M. Egyed, M. L. Fox, D. McLornan, A. Perkins, S.-S. Yoon, V. Gupta, J.-J. Kiladjian, R. Donahue, J. Kawashima, S. Verstovsek
Publikováno v:
HemaSphere, Vol 6, Pp 940-941 (2022)
Externí odkaz:
https://doaj.org/article/2c1ea77aeb224783a0dc76938e1ba7b3
Publikováno v:
Advances in Space Research. 71:5400-5412
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd5438b0dd11e0f3dd5600cc904cb60b
https://doi.org/10.1016/j.asr.2023.02.034
https://doi.org/10.1016/j.asr.2023.02.034
Autor:
Ruben A. Mesa, Stacie Hudgens, Lysbeth Floden, Claire N. Harrison, Jeanne Palmer, Vikas Gupta, Donal P. McLornan, Mary F. McMullin, Jean‐Jaques Kiladjian, Lynda Foltz, Uwe Platzbecker, M. Laura Fox, Adam J. Mead, David M. Ross, Stephen T. Oh, Andrew Perkins, Michael F. Leahy, Samineh Deheshi, Rafe Donahue, Barbara J. Klencke, Srdan Verstovsek
Publikováno v:
Mesa, R A, Hudgens, S, Floden, L, Harrison, C N, Palmer, J, Gupta, V, McLornan, D P, McMullin, M F, Kiladjian, J-J, Foltz, L, Platzbecker, U, Fox, M L, Mead, A J, Ross, D M, Oh, S T, Perkins, A, Leahy, M F, Deheshi, S, Donahue, R, Klencke, B J & Verstovsek, S 2023, ' Symptomatic benefit of momelotinib in patients with myelofibrosis: results from the SIMPLIFY phase III studies ', Cancer Medicine . https://doi.org/10.1002/cam4.5799
Scientia
Scientia
Momelotinib; Myelofibrosis; Patient-reported outcomes Momelotinib; Mielofibrosi; Resultats informats pel pacient Momelotinib; Mielofibrosis; Resultados informados por el paciente Background Myelofibrosis (MF)-associated constitutional symptoms can se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcfbb9cc40d930868fce1d2a253b5f47
https://doi.org/10.1002/cam4.5799
https://doi.org/10.1002/cam4.5799